Electrophilic nitro-fatty acids: anti-inflammatory mediators in the vascular compartment.
about
Macrophages and Their Role in Atherosclerosis: Pathophysiology and Transcriptome AnalysisDo antioxidants impair signaling by reactive oxygen species and lipid oxidation products?Current perspectives and challenges in understanding the role of nitrite as an integral player in nitric oxide biology and therapyOxidases and peroxidases in cardiovascular and lung disease: new concepts in reactive oxygen species signalingNrf2 and the promotion of atherosclerosis: lessons to be learnedNitrated fatty acids modulate the physical properties of model membranes and the structure of transmembrane proteins.Phenotypic modulation of macrophages in response to plaque lipids.Electrophilic fatty acid species inhibit 5-lipoxygenase and attenuate sepsis-induced pulmonary inflammation.Rac1 modification by an electrophilic 15-deoxy Δ(12,14)-prostaglandin J2 analog.Regulation of keratinocyte expression of stress proteins and antioxidants by the electrophilic nitrofatty acids 9- and 10-nitrooleic acid.Formation and signaling actions of electrophilic lipidsHeme oxygenase-1, oxidation, inflammation, and atherosclerosisNitro-fatty acids in cardiovascular regulation and diseases: characteristics and molecular mechanisms.Electrophilic nitro-fatty acids inhibit vascular inflammation by disrupting LPS-dependent TLR4 signalling in lipid rafts.Protection of nitro-fatty acid against kidney diseases.Characterization and quantification of endogenous fatty acid nitroalkene metabolites in human urine.Influence of nutrition in PCB-induced vascular inflammation.Combined losartan and nitro-oleic acid remarkably improves diabetic nephropathy in mice.Macrophages and Their Contribution to the Development of Atherosclerosis.KMUP-1 inhibits H441 lung epithelial cell growth, migration and proinflammation via increased NO/CGMP and inhibited RHO kinase/VEGF signaling pathways.Nitro-oleic acid inhibits vascular endothelial inflammatory responses and the endothelial-mesenchymal transition.Profiling and relative quantification of multiply nitrated and oxidized fatty acids.Inflammatory signaling and metabolic regulation by nitro-fatty acids.Lipoxins, resolvins, protectins, maresins and nitrolipids, and their clinical implications with specific reference to cancer: part ILipoxins, resolvins, protectins, maresins and nitrolipids, and their clinical implications with specific reference to diabetes mellitus and other diseases: part II
P2860
Q26738772-F64D3251-7BB6-41EB-9CB9-3807470B5760Q26864665-29C3D788-AB73-4489-94C4-7186FF88B180Q28390815-9DF4A0E4-0484-4BBF-B813-38DA09BD72D8Q28393242-21920A83-3719-4F1B-BE11-0F429F32754BQ29541148-00CFB84C-DFFD-43D4-9D45-603CEC10F50CQ30401963-9A649FB1-7978-4695-9740-46479E71E409Q30413906-BCBD37D7-75F8-4BD2-BFB3-31FCFFDB7E73Q33632763-A8DED2A3-DB60-481F-8B39-A652ABC7EEC7Q35078149-7B6BD840-881D-43D3-8B7A-946444F481E8Q35343637-827567FD-E649-4A79-8FD6-EF823D9B1EA7Q35804051-A86C88F8-0B45-48BD-ADC0-7701CF26BC35Q36103851-1413185B-D494-4063-AECA-DAAE2153C825Q36565424-1C9C0100-EA31-44E5-8A1B-2A5E437F6742Q36687046-6F7F91D3-A294-48E4-A432-0E0D89BED060Q36810720-49593903-8F71-43C0-AB68-810052E5E705Q36920628-EF4EAE96-451A-40C2-BD5F-42EC843C6D38Q36941019-12F89ACB-0831-44A0-95B3-E55D293F6A71Q37439729-F7D48413-0FF6-4AC9-B18A-0EE9B9761CB2Q39271642-A8E6505F-6DFE-48DE-A6DE-69B7E95FE662Q39415018-B9BECFC3-5CE7-4A95-BBE2-011C9071AAB3Q42620946-744F0B03-8AD9-4D8E-9FC9-3D40BA9252C6Q46722547-4B020010-EC75-4574-B371-B63DB7EAAC4FQ52631728-FB87ACE2-3BA2-44C1-8062-14932DC35892Q56699407-644D8555-00CF-44D2-8184-BAD51DD72639Q56699408-99DECF15-F2B7-4C8F-94BA-6C7946564B0A
P2860
Electrophilic nitro-fatty acids: anti-inflammatory mediators in the vascular compartment.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Electrophilic nitro-fatty acids: anti-inflammatory mediators in the vascular compartment.
@ast
Electrophilic nitro-fatty acids: anti-inflammatory mediators in the vascular compartment.
@en
type
label
Electrophilic nitro-fatty acids: anti-inflammatory mediators in the vascular compartment.
@ast
Electrophilic nitro-fatty acids: anti-inflammatory mediators in the vascular compartment.
@en
prefLabel
Electrophilic nitro-fatty acids: anti-inflammatory mediators in the vascular compartment.
@ast
Electrophilic nitro-fatty acids: anti-inflammatory mediators in the vascular compartment.
@en
P2860
P1476
Electrophilic nitro-fatty acids: anti-inflammatory mediators in the vascular compartment.
@en
P2093
Bruce A Freeman
Nicholas K H Khoo
P2860
P304
P356
10.1016/J.COPH.2009.11.003
P577
2010-01-14T00:00:00Z